A new hope? Possibilities of therapeutic IgA antibodies in the treatment of inflammatory lung diseases
F Bohländer - Frontiers in Immunology, 2023 - frontiersin.org
Inflammatory lung diseases represent a persistent burden for patients and the global
healthcare system. The combination of high morbidity,(partially) high mortality and limited …
healthcare system. The combination of high morbidity,(partially) high mortality and limited …
Recombinant neutralizing secretory IgA antibodies for preventing mucosal acquisition and transmission of SARS-CoV-2
K Göritzer, E Groppelli, C Grünwald-Gruber, R Figl… - Molecular Therapy, 2024 - cell.com
Passive delivery of antibodies to mucosal sites may be a valuable adjunct to COVID-19
vaccination to prevent infection, treat viral carriage, or block transmission. Neutralizing …
vaccination to prevent infection, treat viral carriage, or block transmission. Neutralizing …